Cepheid Files Answer and Counterclaims in Abaxis Patent Suit
July 13, 2010
SUNNYVALE, Calif. - Cepheid (Nasdaq: CPHD) announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis' allegations of patent infringement, asked the Court to determine it [...]
Ariadne Technology Licensed by Takeda for Evaluation of Potential Antibody Targets
July 13, 2010
Rockville, MD - Ariadne announces that Takeda San Francisco, Takeda's global center for excellence for biologics, has signed an agreement to license Ariadne's Pathway Studio® software. Takeda plans to utilize the software and underlying text-mining algorithms in their discovery program against cancer, inflammatory and metabolic diseases. "We are pleased to add Takeda to our already [...]
July 13, 2010
Vancouver, B.C. - EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave” or “the Company") has announced that it has begun testing a multiple-vial prototype of the Company’s freezeREVTM pharmaceutical dehydration technology designed to dry standard industry serum vials containing vaccines, injectable drugs, analytical enzymes, diagnostic reagents, antibodies and other biological materials. The new multiple-vial prototype has a [...]
Universal Detection Technology Adds Mold Detection Device to Biohazard Detection Product Catalog
July 13, 2010
Device Equips Homeowners and Health Officials With Rapid Detection of Toxic Mold, Detects the Top Three Mold Species: Stachybotrys, Penicillium and Aspergillus LOS ANGELES, CA - Universal Detection Technology (www.udetection.com) (UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, announced today that it has expanded its product [...]
Malvern: Reverse Engineering Tablets for Counterfeit Investigations
July 13, 2010
Malvern, UK: Chemical imaging specialists at Malvern Instruments are demonstrating how data derived from reverse engineering of pharmaceutical tablets can aid the fight against counterfeit drugs. Using the SyNIRgi near infrared chemical imaging (NIRCI) system they have been able to collect data detailed enough to characterize the formulation and processes used to create individual dosages. [...]
Genego’s ToxHunter™ Suite of Tools and Content for Systems Toxicology Research Now Available
July 13, 2010
St. Joseph, Michigan – GeneGo announced the availability of ToxHunter™, the first commercial release of tools and content developed through its industry-FDA MetaTox™ partnership program, a collaborative program developing a unique comprehensive systems toxicology suite designed for compound safety assessment in chemical and pharmaceutical R&D. ToxHunter is now available as an add-on to existing licenses [...]
Asuragen and Life Technologies Launch CE-Marked BCR/ABL1 Quant™ Leukemia Test in Europe
July 13, 2010
AUSTIN, Tex and CARLSBAD, Calif. - Asuragen, Inc. and Life Technologies Corporation (NASDAQ: LIFE) announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant™ Test, Asuragen’s clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). [...]
Meridian Bioscience Receives FDA Clearance for New illumigene(TM) Molecular Platform
July 13, 2010
CINCINNATI - Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its new molecular amplification assay, illumigene(TM) C.difficile. Clostridium difficile is a bacterium that can cause diarrhea and, in severe cases, a life-threatening inflammation of the colon. The illumigene molecular amplification assay [...]
InQ Biosciences Introduces First Fully Integrated Cellular Research System
July 13, 2010
HUNTSVILLE, ALABAMA, U.S.A. - InQ Biosciences, a provider of innovative technologies for cell growth and research, announced its plans to launch the InQTM Cell Research System during the fourth quarter of 2010. InQ is the first fully integrated system that creates a high fidelity in vivo environment for studying stem cells, plus nerve, brain, and [...]
July 12, 2010
SOUTH EASTON, Mass. - Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company") today announced that Mr. Alan I. Goldberg has been unanimously elected to fill the open, Class III seat on the Company's Board of Directors, effective Monday, July 12, 2010. This seat has been vacant since shareholders voted to amend the Company's Articles of [...]

